Opinion

Video

Parkinson Disease: Prevalence and Impact of OFF Episodes and Dyskinesia

Author(s):

Daniel E. Kremens, MD, JD

An expert discusses how providers can accurately track episodes of OFF and dyskinesia, highlighting their impact on patients physically, socially, and psychologically, including the challenges dyskinesia poses for sleep and fine motor tasks.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Molly Abbott, BM BCh
Esther Labib-Kiyarash, MSHA, CPHQ
Justin Martello, MD
William Ondo, MD
Jennifer Corcoran, MD
Marcia Pasqualini, PhD
Related Content
Exablate Neuro Gains FDA Approval for Staged Bilateral Focused Ultrasound in Advanced Parkinson Disease
July 9th 2025

Exablate Neuro Gains FDA Approval for Staged Bilateral Focused Ultrasound in Advanced Parkinson Disease

Isabella Ciccone, MPH
Multisymptomatic Care in Parkinson's Disease
September 4th 2024

Multisymptomatic Care in Parkinson's Disease

Stuart H. Isaacson, MD, FAAN Rajesh Pahwa, MD Jennifer G. Goldman, MD, MS
Reduction in Parkinson OFF Episodes Through Subcutaneous Apomorphine Infusion Leads to Doubling of Good ON Time
July 3rd 2025

Reduction in Parkinson OFF Episodes Through Subcutaneous Apomorphine Infusion Leads to Doubling of Good ON Time

Marco Meglio
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
April 9th 2024

Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Anne Marie Morse, DO, FAASM NeurologyLive® Staff
NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease
July 2nd 2025

NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease

Isabella Ciccone, MPH Cheryl Kyinn, PA-C
Subcutaneous Foslevodopa/Foscarbidopa Enhances Sleep and QoL Synergistically in Parkinson Disease
June 29th 2025

Subcutaneous Foslevodopa/Foscarbidopa Enhances Sleep and QoL Synergistically in Parkinson Disease

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.